Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    Open Studies | "Kidney Diseases, Cystic"
Show Display Options
Rank Status Study
21 Recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
22 Recruiting Clinical and Molecular Description of PKD1 and PKD2 Mutation Negative Carriers in ADPKD
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Intervention: Other: Blood Collection
23 Recruiting Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease
Conditions: Polycystic Kidney, Type 1 Autosomal Dominant Disease;   Polycystic Kidney, Type 2 Autosomal Dominant Disease
Interventions: Drug: Sirolimus;   Drug: Placebo
24 Recruiting PKD Clinical and Translational Core Study
Condition: Polycystic Kidney Disease
Intervention:
25 Recruiting A Safety, Pharmacokinetic and Dose-Escalation Study of KD019 in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Polycystic Kidney, Autosomal Dominant
Intervention: Drug: KD019 (tesevatinib)
26 Recruiting Polycystic Kidney Disease Data Repository
Condition: Polycystic Kidney Disease
Intervention:
27 Recruiting Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study
Condition: Kidney, Polycystic, Autosomal Dominant
Intervention: Procedure: video thorascopic splanchnicectomy (VSPL)
28 Recruiting Feasibility Study of Metformin Therapy in ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Metformin;   Drug: Placebo
29 Recruiting Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Intervention: Drug: tolvaptan
30 Recruiting Curcumin Therapy to Treat Vascular Dysfunction in Children and Young Adults With ADPKD
Condition: Polycystic Kidney, Autosomal Dominant
Interventions: Drug: Curcumin;   Other: Placebo
31 Recruiting Clinical Care of Autosomal Polycystic Kidney Disease: Retrospective Analysis and Prospective PKD Genotyping
Condition: ADPKD
Intervention:
32 Recruiting Pioglitazone and Lumbar Bone Marrow Fat in Chronic Kidney Disease
Condition: Polycystic Kidney Diseases
Intervention: Other: No intervention
33 Recruiting UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Conditions: Hepato/Renal Fibrocystic Disease;   Autosomal Recessive Polycystic Kidney Disease;   Joubert Syndrome;   Bardet Biedl Syndrome;   Meckel-Gruber Syndrome;   Congenital Hepatic Fibrosis;   Caroli Syndrome;   Oro-Facial-Digital Syndrome Type I;   Nephronophthisis;   Glomerulocystic Kidney Disease
Intervention:
34 Not yet recruiting CTT on Renogram as an Early Marker of Significant Obstruction in Uretero-pelvic Junction Syndrome
Condition: Ureteropelvic Junction Obstruction
Interventions: Device: ultrasonography;   Device: diuretic renography
35 Recruiting Indwelling Double-J Ureteral Stent Versus Externalized Modified-Salle Stent for Pyeloplasty
Condition: Ureteropelvic Junction Obstruction
Interventions: Other: internal Double-J stents;   Other: External Stent
36 Recruiting Randomized Trial of NSAID vs Placebo Prior to Ureteral Stent Removal
Conditions: Disorder of Urinary Stent;   Ureteral Spasm;   Ureteropelvic Junction Obstruction;   Urolithiasis
Interventions: Drug: Ibuprofen;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-36) Next Page   
Study has passed its completion date and status has not been verified in more than two years.